Skip to main content
Premium Trial:

Request an Annual Quote

BD, HandyLab Partner on MDx Test System

NEW YORK (GenomeWeb News) — Becton Dickinson said today that it has reached an agreement to market some of its pathogen tests using HandyLab's molecular diagnostic platform.

BD said it will market its molecular diagnostic assays on a new BD MAX system, which uses Handylab's Jaguar system.

The Jaguar system incorporates clinical sample preparation, nucleic acid extraction, microfluidic real-time PCR amplification and detection. HandyLab launched the system in November 2008.

BD said it will initially focus on using its GeneOhm assays that detect pathogens responsible for hospital-acquired infections, such as its tests for methicillin-resistant staphylococcus aureus and toxigenic Clostridium difficile, in the new system.

"As our customers expand their HAI and sexually transmitted infection testing programs, they are seeking simple, flexible and fully automated systems to meet their increasing demands," Philippe Jacon, president of BD Diagnostics – Diagnostic Systems, said in a statement. "Our new BD MAX system will be a good strategic fit with our current platforms and those under development."

Financial terms of the agreement were not released.

Filed under

The Scan

Unwrapping Mummies' Faces

LiveScience reports that Parabon NanoLabs researchers have reconstructed how three Egyptian mummies may have looked.

Study on Hold

The Spectrum 10K study has been put on hold due to a backlash, leading the researchers to conduct consultations with the autism community, Nature News reports.

Others Out There Already

Reuters reports that Sanofi is no longer developing an mRNA-based vaccine for SARS-CoV-2.

PNAS Papers on GWAS False Discovery, PRAMEF2 Role in Tumorigenesis, RNA Virus Reverse Genetics

In PNAS this week: strategy to account for GWAS false-discovery rates, role of PRAMEF2 in cancer development, and more.